Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Nature Biomedical Engineering
|
April 2, 2019
Biodegradable and flexible arterial-pulse sensor for the wireless monitoring of blood flow
Clementine M Boutry, Levent Beker, Yukitoshi Kaizawa, et al.
American Journal of Clinical Dermatology
|
June 18, 2026
Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, et al.
American Journal of Clinical Dermatology
|
September 15, 2025
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, et al.
American Journal of Clinical Dermatology
|
January 23, 2024
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, et al.
American Journal of Clinical Dermatology
|
May 24, 2024
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, et al.
Burns : Journal of the International Society for Burn Injuries
|
February 18, 2026
Analysis of treatment pathways and long-term prevalence of pruritus after burn - An observational study with real-world data
Julia Kleinhapl, Lucineia Gainski Danielski, John Nabei Ekale, et al.
Journal of the American Academy of Dermatology
|
October 18, 2024
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
Melissa Piliang, Charles Lynde, Brett King, et al.
Dermatology and Therapy
|
March 25, 2026
Validation of Self-Reported Vitiligo Prevalence among Adults in the USA and Europe Using the 2024 National Health and Wellness Survey
Seemal R Desai, Khaled Ezzedine, Markus Böhm, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
October 24, 2006
Mapping cortical thickness in children with 22q11.2 deletions
Carrie E Bearden, Theo G M van Erp, Rebecca A Dutton, et al.
American Journal of Medical Genetics. Part A
|
July 2, 2003
Relation between apolipoprotein E genotype, hepatitis B virus status, and thyroid status in a sample of older persons with Down syndrome
Maire E Percy, Zoya Potyomkina, Arthur J Dalton, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Nature Biomedical Engineering
|
April 2, 2019
Biodegradable and flexible arterial-pulse sensor for the wireless monitoring of blood flow
Clementine M Boutry, Levent Beker, Yukitoshi Kaizawa, et al.
American Journal of Clinical Dermatology
|
June 18, 2026
Correction: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, et al.
American Journal of Clinical Dermatology
|
September 15, 2025
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, et al.
American Journal of Clinical Dermatology
|
January 23, 2024
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, et al.
American Journal of Clinical Dermatology
|
May 24, 2024
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Brett King, Jennifer Soung, Christos Tziotzios, et al.
Burns : Journal of the International Society for Burn Injuries
|
February 18, 2026
Analysis of treatment pathways and long-term prevalence of pruritus after burn - An observational study with real-world data
Julia Kleinhapl, Lucineia Gainski Danielski, John Nabei Ekale, et al.
Journal of the American Academy of Dermatology
|
October 18, 2024
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
Melissa Piliang, Charles Lynde, Brett King, et al.
Dermatology and Therapy
|
March 25, 2026
Validation of Self-Reported Vitiligo Prevalence among Adults in the USA and Europe Using the 2024 National Health and Wellness Survey
Seemal R Desai, Khaled Ezzedine, Markus Böhm, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
October 24, 2006
Mapping cortical thickness in children with 22q11.2 deletions
Carrie E Bearden, Theo G M van Erp, Rebecca A Dutton, et al.
American Journal of Medical Genetics. Part A
|
July 2, 2003
Relation between apolipoprotein E genotype, hepatitis B virus status, and thyroid status in a sample of older persons with Down syndrome
Maire E Percy, Zoya Potyomkina, Arthur J Dalton, et al.
Page
of 8